Get started
OKYO Pharma LimitedOKYO Pharma LimitedOKYO Pharma Limited

OKYO Pharma Limited

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

OKYO chart


Full chart

OKYO upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪51.23 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−16.83 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪24.54 M‬
Beta (1Y)
0.39

About OKYO Pharma Limited


Sector
Health Technology
Industry
Biotechnology
CEO
Gary S. Jacob
Website
okyopharma.com
Headquarters
London
Founded
2007
ISIN
GG00BMFG5F62
FIGI
BBG015TS35V5
OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It operates through the US and UK geographical segments. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

OKYO news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as OKYO.